MC1R variant alleles and malignant melanoma risk in Israel

2009 ◽  
Vol 45 (11) ◽  
pp. 2015-2022 ◽  
Author(s):  
Gilli Galore-Haskel ◽  
Esther Azizi ◽  
Hamida Mohamdi ◽  
Alon Scope ◽  
Valérie Chaudru ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Melanoma Risk ◽  
Mc1r Variant ◽  
Variant Alleles

Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study

2008 ◽  
Vol 19 (7) ◽  
pp. 759-765 ◽  
Author(s):  
Charlotte Gerd Hannibal ◽  
Allan Jensen ◽  
Heidi Sharif ◽  
Susanne Krüger Kjaer
Keyword(s):  
Cohort Study ◽  
Malignant Melanoma ◽  
Melanoma Risk ◽  
Fertility Drugs ◽  
Danish Cohort

scholarly journals Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis

2020 ◽  
Vol 63 (3) ◽  
pp. 101-112
Author(s):  
Fatemeh Asadian ◽  
Seyed Mohammadreza Niktabar ◽  
Yaser Ghelmani ◽  
Shadi Kargar ◽  
Elahe Akbarian ◽  
...  
Keyword(s):  
Malignant Melanoma ◽  
Meta Analysis ◽  
Complementation Group ◽  
Cutaneous Malignant Melanoma ◽  
Case Control Studies ◽  
Melanoma Risk ◽  
Pooled Data ◽  
Increased Risk ◽  
Pcr Rflp ◽  
Rflp Assay

Background: A number of studies have reported that the xeroderma pigmentosum complementation group C (XPC) polymorphisms are associated with cutaneous malignant melanoma (CMM) susceptibility. But the results of those studies were inconsistent. Here, we performed a study to obtain a more conclusive result on the association of XPC polymorphisms with risk of CMM. Methods: The XPC Lys939Gln and Ala499Val polymorphisms were genotyped in 150 CMM cases and 150 controls by PCR-RFLP assay. Subsequently, all published relevant studies were identified through a comprehensive literature search in PubMed, Web of Science, and CNKI databases. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to estimate the strength of correlation. Results: There was no significant association between XPC Lys939Gln and Ala499Val polymorphisms and CMM risk in our population. A total of 15 case-control studies including ten studies with 5,990 cases and 7,697 controls on XPC Lys939Gln and five studies with 3,139 cases and 3,721 controls on XPC Ala499Val polymorphism were selected. Pooled data revealed that XPC Lys939Gln (C vs. A: OR = 1.108, 95% CI 1.008– 1.217; P = 0.033) and Ala499Val (C vs. A: OR = 0.918, 95% CI 0.850–0.992; p = 0.031; CC+CA vs. AA: OR = 0.904, 95% CI 0.819–0.997; p = 0.043) polymorphisms were significantly associated with an increased risk of CMM. Moreover, stratified analyses by ethnicity revealed that the XPC Ala499Val and Lys939Gln polymorphisms were significantly associated with risk of CMM in Caucasians and mixed populations, respectively. Conclusions: This meta-analysis result suggested that XPC Lys939Gln and Ala499Val polymorphisms were significantly associated with risk of CMM.

scholarly journals Assessment of Malignant Melanoma Risk Factors and Their Attitudes Towards Protection from the Sun in Patients Applying to Family Physician Polyclinics

2017 ◽  
pp. 1-6
Author(s):  
Ezgi Ağadayı ◽  
Aybüke Demir Alsancak ◽  
Duygu Üstünol ◽  
İrfan Şencan ◽  
Hatice Küçükceran ◽  
...  
Keyword(s):  
Risk Factors ◽  
Malignant Melanoma ◽  
Family Physician ◽  
The Sun ◽  
Melanoma Risk

scholarly journals SUNSCREEN USE AND MALIGNANT MELANOMA RISK: THE JURY IS STILL OUT

2003 ◽  
Vol 93 (1) ◽  
pp. 11-b-12 ◽  
Author(s):  
Stephen W. Marshall ◽  
Charles Poole ◽  
Anna E. Waller
Keyword(s):  
Malignant Melanoma ◽  
Melanoma Risk ◽  
Sunscreen Use

TNF inhibitors increase malignant melanoma risk

2013 ◽  
Vol 1449 (1) ◽  
pp. 3-3
Keyword(s):  
Malignant Melanoma ◽  
Tnf Inhibitors ◽  
Melanoma Risk

scholarly journals Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles

2007 ◽  
Vol 16 (18) ◽  
pp. 2249-2260 ◽  
Author(s):  
K. A. Beaumont ◽  
S. L. Shekar ◽  
R. A. Newton ◽  
M. R. James ◽  
J. L. Stow ◽  
...  
Keyword(s):  
Dominant Negative ◽  
Receptor Function ◽  
Mc1r Variant ◽  
Variant Alleles ◽  
Dominant Negative Activity

“Thin” Malignant Melanoma: Risk Factors and Clinical Management

1992 ◽  
Vol 28 (1) ◽  
pp. 89-94 ◽  
Author(s):  
Craig L. Slingluff ◽  
Hilliard F. Seigler
Keyword(s):  
Risk Factors ◽  
Malignant Melanoma ◽  
Clinical Management ◽  
Melanoma Risk

scholarly journals Higher Caffeinated Coffee Intake Is Associated with Reduced Malignant Melanoma Risk: A Meta-Analysis Study

PLoS ONE ◽  
2016 ◽  
Vol 11 (1) ◽  
pp. e0147056 ◽  
Author(s):  
Jibin Liu ◽  
Biao Shen ◽  
Minxin Shi ◽  
Jing Cai
Keyword(s):  
Malignant Melanoma ◽  
Meta Analysis ◽  
Melanoma Risk ◽  
Coffee Intake ◽  
Analysis Study ◽  
Caffeinated Coffee

Malignant melanoma risk by nativity, place of residence at diagnosis, and age at migration

1991 ◽  
Vol 2 (6) ◽  
pp. 401-411 ◽  
Author(s):  
Thomas M. Mack ◽  
Birgitta Floderus
Keyword(s):  
Malignant Melanoma ◽  
Place Of Residence ◽  
Melanoma Risk ◽  
Age At Migration
Sign in / Sign up

Export Citation Format

Share Document